MarketScreener Homepage > Equities > Tokyo Stock Exchange > FUJIFILM Holdings Corporation 4901 JP3814000000

Report

End-of-day quote Tokyo Stock Exchange - 02/26
6070	JPY		-3.96%

02/21

FUJIFILM : to restart clinical trial of Avigan to treat COVID-19 - media

02/21

FUJIFILM : to restart clinical trial of Avigan to treat COVID-19 - media

02/19

GLOBAL MARKETS LIVE: Novavax, IBM, Swiss Re…

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Tokyo Stock Exchange

02/19/2021	02/22/2021	02/24/2021	02/25/2021	02/26/2021	Date
6338	6333	6265	6320	6070	Last
1089500	1058200	1311600	1154400	2039700	Volume
-0.19%	-0.08%	-1.07%	+0.88%	-3.96%	Change

Financials

Sales 2021	2 184 B 20 587 M 20 587 M
Net income 2021	141 B 1 334 M 1 334 M
Net Debt 2021	186 B 1 750 M 1 750 M
P/E ratio 2021	18,2x
Yield 2021	1,54%

Sales 2022	2 350 B 22 155 M 22 155 M
Net income 2022	151 B 1 425 M 1 425 M
Net Debt 2022	122 B 1 153 M 1 153 M
P/E ratio 2022	16,5x
Yield 2022	1,62%

Capitalization	2 527 B 23 780 M 23 821 M
EV / Sales 2021	1,24x
EV / Sales 2022	1,13x
Nbr of Employees	73 906
Free-Float	73,9%

More Financials

Company

Fujifilm Holdings Corporation specializes in the manufacturing and marketing of printing, imaging and photography materials and equipment. Net sales break down by activity as follows: - sale of printers and photocopiers (42.7%); - sale of medical imaging equipment (41.4%): digital endoscopes, digital mammography devices, radiologic tables, ultrasound scan systems, etc. The group also develops pharmaceutical...

Sector

Office Equipment

Calendar

03/30

Ex-dividend day for final dividend

More about the company

Notations Surperformance© of FUJIFILM Holdings Corporation

Trading Rating :

Investor Rating :

More Ratings

All news about FUJIFILM HOLDINGS CORPORATION

02/21	FUJIFILM : to restart clinical trial of Avigan to treat COVID-19 - media	RE
02/21	FUJIFILM : to restart clinical trial of Avigan to treat COVID-19 - media	RE
02/19	GLOBAL MARKETS LIVE: Novavax, IBM, Swiss Re…
02/18	FUJIFILM : to Complete Acquisition of Hitachi Diagnostic Imaging Business on Mar..	MT
02/18	FUJIFILM : Avigan shows no significant benefit on COVID-19 mortality - study	RE
02/18	SYNTHETICMR : Year-End report January - December 2020	AQ
02/17	US judge dismisses aluminum antitrust claims	RE
02/10	FUJIFILM : Posts Higher Attributable Net Income in April-December 2020; Shares R..	MT
01/27	India's Dr.Reddy's ends study of COVID-19 drug Avigan in Kuwait	RE
01/27	FUJIFILM : Japan's Fujifilm to open cancer screening center in southern India	AQ
01/06	FUJIFILM : says will invest $2 billion in new large-scale cell culture productio..	RE
2020	Nikkei 225 Off 1% on Renewed Pandemic Concerns	MT
2020	Nikkei hits 3-week low as new virus strain damps recovery hopes	RE
2020	Japanese shares drop as new virus strain sparks profit-taking	RE
2020	CORRECTION ( : Vietnam-Fujifilm:)	AQ

More news

News in other languages on FUJIFILM HOLDINGS CORPORATION

02/22	Tokyo repart de l'avant sur des espoirs de reprise
02/21	Tokyo rebondit après une fin de semaine dans le rouge
02/19	Des PMI et des sorcières pour terminer la semaine
02/19	EN DIRECT DES MARCHES : Renault, Danone, Hermès, Gecina, Neoen, Tesla, IBM, Sika..
02/05	EN DIRECT DES MARCHES : Sanofi, Vinci, BNP Paribas, Vallourec, Ford, Enel, Apple..

More news

Provided by Scoopnest.com

Analysis

Fujifilm : says will invest $2 billion in new large-scale cell culture production site in U.S

More Must read

Chart FUJIFILM HOLDINGS CORPORATION

Duration : Period :

FUJIFILM Holdings Corporation Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends FUJIFILM HOLDINGS CORPORATION

	Short Term	Mid-Term	Long Term
Trends	Neutral	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	BUY
Number of Analysts	16
Average target price	6 980,00 JPY
Last Close Price	6 320,00 JPY
Spread / Highest target	58,2%
Spread / Average Target	10,4%
Spread / Lowest Target	-16,1%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Shigetaka Komori	Chairman & Group Chief Executive Officer
Kenji Sukeno	President, Group COO & Representative Director
Takashi Iwasaki	Director & Chief Technology Officer
Kunitaro Kitamura	Independent Outside Director
Tatsuo Kawada	Independent Outside Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

FUJIFILM HOLDINGS CORPORATION	16.22%	23 780



CANON INC.	20.30%	23 094
RICOH COMPANY, LTD.	44.61%	6 522
BROTHER INDUSTRIES, LTD.	1.51%	5 294
KONICA MINOLTA, INC.	43.91%	2 543
TOSHIBA TEC CORPORATION	6.31%	1 994

More Results